[HTML][HTML] Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region-A open labelled single arm …

S Dattatreya, C Goswami - Indian Journal of Cancer, 2011 - journals.lww.com
Purpose: To evaluate feasibility, safety and outcome of cetuximab concurrent with
radiotherapy in locally advanced head− neck cancer. Materials and Methods: Between …

[HTML][HTML] Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent …

JP Agarwal, T Gupta, N Kalyani… - Indian Journal of …, 2011 - journals.lww.com
Purpose: To report outcomes of cetuximab concurrent with radiotherapy in advanced head-
neck cancer unsuitable for platinum-based chemo-radiotherapy. Materials and Methods …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer management …, 2010 - Taylor & Francis
Introduction The purpose of this study was to evaluate the clinical efficacy in our daily
practice, outside clinical trials, of cetuximab plus radiotherapy in a majority of treatment …

Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity

CM Acevedo-Henao, G Valette, P Miglierini, E Lefur… - Cancer …, 2012 - Elsevier
PURPOSE: To describe the clinical results and tolerance of the combined treatment with
radiotherapy and cetuximab for locally advanced head and neck cancer. PATIENTS AND …

Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current …

G Numico, P Franco, A Cristofano, F Migliaccio… - Critical reviews in …, 2013 - Elsevier
The administration of Cetuximab in combination with radiotherapy and chemotherapy has
shown clear survival improvements within the locally advanced and the relapsed/metastatic …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck

JE Frampton - Drugs, 2010 - Springer
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with …

JA Bonner, PM Harari, J Giralt, N Azarnia… - Journal of Clinical …, 2004 - ascopubs.org
5507 Background: The majority of head and neck cancers overexpress the epidermal
growth factor receptor (EGFR), which is associated with aggressive tumor behavior and poor …

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

F Perri, F Longo, F Ionna, F Caponigro - OncoTargets and therapy, 2009 - Taylor & Francis
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor
receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In …

Spotlight on cetuximab in squamous cell carcinoma of the head and necky

JE Frampton - BioDrugs, 2011 - Springer
Cetuximab (Erbitux®) is a chimeric monoclonal antibody directed against the human
epidermal growth factor receptor (EGFR). EGFR is overexpressed and/or upregulated in …

[引用][C] Combining cetuximab with chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: is more better?

A Psyrri, U Dafni - Journal of clinical oncology: official journal of the …, 2014 - europepmc.org
Combining cetuximab with chemoradiotherapy in locally advanced head and neck squamous
cell carcinoma: is more better? - Abstract - Europe PMC Sign in | Create an account …